In-Silico Antibody Development with AlphaBind Using NVIDIA BioNeMo and AWS HealthOmics

Image shows a 3D molecular structure of a protein, most likely an antibody, visualized using a ribbon diagram, with the classic Y-shaped configuration characteristic of antibodies.

Antibodies have become the most prevalent class of therapeutics, primarily due to their ability to target specific antigens, enabling them to treat a wide range…

Antibodies have become the most prevalent class of therapeutics, primarily due to their ability to target specific antigens, enabling them to treat a wide range of diseases, from cancer to autoimmune disorders. Their specificity reduces the likelihood of off-target effects, making them safer and often more effective than small-molecule drugs for complex conditions. As a result…

Source

Source:: NVIDIA